Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

22.38
+0.92504.31%
Volume:158.84K
Turnover:3.52M
Market Cap:919.61M
PE:47.47
High:22.45
Open:21.47
Low:21.47
Close:21.45
52wk High:27.64
52wk Low:18.80
Shares:41.10M
Float Shares:37.84M
Volume Ratio:0.55
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4713
EPS(LYR):-2.1529
ROE:2.90%
ROA:2.89%
PB:1.26
PE(LYR):-10.39

Loading ...

Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2025

Major Issues Report

Form 8-K - Current report
Jul 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities